---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-24-001716"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2024-10-18T23:59:59+00:00"
generated_at: "2026-05-30T12:44:36.508210+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Lipella receives Nasdaq delisting notice for equity deficiency; hearing set for Dec 12

## Summary
- Nasdaq notified Lipella of delisting for stockholders' equity of $1.7M, below $2.5M minimum.
- Company appealed by Oct 23, 2024; hearing before Nasdaq Hearings Panel set for Dec 12, 2024.
- Trading suspension stayed pending hearing; stock continues trading on Nasdaq during appeal.
- Bid price non-compliance also outstanding; reverse split approved to address minimum bid requirement.

## SEC filing metadata
- accession: 0001753926-24-001716
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2024-10-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392624001716/0001753926-24-001716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392624001716/g084492_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-24-001716
- JSON: https://secwatch.observer/filing/0001753926-24-001716.json
- Plain text: https://secwatch.observer/filing/0001753926-24-001716.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.